ATC code D11
ATC code D11 Other dermatological preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D11 is part of the anatomical group D Dermatologicals.[4]
| ATC codes |
|---|
| D Dermatologicals |
| D01 Antifungals for dermatological use |
| D02 Emollients and protectives |
| D03 Preparations for treatment of wounds and ulcers |
| D04 Antipruritics, including antihistamines, anesthetics, etc. |
| D05 Antipsoriatics |
| D06 Antibiotics and chemotherapeutics for dermatological use |
| D07 Corticosteroids, dermatological preparations |
| D08 Antiseptics and disinfectants |
| D09 Medicated dressings |
| D10 Anti-acne preparations |
| D11 Other dermatological preparations |
| ATCvet only |
| QD51 Products for the treatment of claws and hoofs |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD11.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
D11A Other dermatological preparations
D11AA Antihidrotics
- D11AA01 Glycopyrronium
D11AC Medicated shampoos
- D11AC01 Cetrimide
- D11AC02 Cadmium compounds
- D11AC03 Selenium compounds
- D11AC06 Povidone-iodine
- D11AC08 Sulfur compounds
- D11AC09 Xenysalate
- D11AC30 Others
D11AE Androgens for topical use
- D11AE01 Metandienone
D11AH Agents for dermatitis, excluding corticosteroids
- D11AH01 Tacrolimus
- D11AH02 Pimecrolimus
- D11AH03 Cromoglicic acid
- D11AH04 Alitretinoin
- D11AH05 Dupilumab
- D11AH06 Crisaborole
- D11AH07 Tralokinumab
- D11AH08 Abrocitinib
- QD11AH90 Oclacitinib
- QD11AH91 Lokivetmab
D11AX Other dermatologicals
- D11AX01 Minoxidil
- D11AX02 Gamolenic acid
- D11AX03 Calcium gluconate
- D11AX04 Lithium succinate
- D11AX05 Magnesium sulfate
- D11AX06 Mequinol
- D11AX08 Tiratricol
- D11AX09 Oxaceprol
- D11AX10 Finasteride
- D11AX11 Hydroquinone
- D11AX12 Pyrithione zinc
- D11AX13 Monobenzone
- D11AX16 Eflornithine
- D11AX18 Diclofenac
- D11AX21 Brimonidine
- D11AX22 Ivermectin
- D11AX23 Aminobenzoate potassium
- D11AX24 Deoxycholic acid
- D11AX25 Hydrogen peroxide
- D11AX26 Caffeine
- D11AX27 Oxymetazoline
- D11AX52 Gamolenic acid, combinations
- D11AX57 Collagen, combinations
- QD11AX90 Benzoylperoxide
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code D11". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QD11". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.